Financials data is unavailable for this security.
View more
Year on year Olympus Corp grew net income 69.12% from 143.43bn to 242.57bn primarily through revenue growth (881.92bn to 936.21bn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 6.16% growth in revenues contributed enough to still see net income improve.
Gross margin | 66.86% |
---|---|
Net profit margin | 2.93% |
Operating margin | 5.05% |
Return on assets | 1.77% |
---|---|
Return on equity | 3.30% |
Return on investment | 2.39% |
More ▼
Cash flow in JPYView more
In 2024, Olympus Corp increased its cash reserves by 65.89%, or 135.42bn. Cash Flow from Investing totalled 359.99bn, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 42.37bn in cash from operations while cash used for financing totalled 276.01bn.
Cash flow per share | 79.42 |
---|---|
Price/Cash flow per share | 31.61 |
Book value per share | 677.69 |
---|---|
Tangible book value per share | 431.79 |
More ▼
Balance sheet in JPYView more
Current ratio | 1.76 |
---|---|
Quick ratio | 1.30 |
Total debt/total equity | 0.3222 |
---|---|
Total debt/total capital | 0.2437 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share increased 12.50% while earnings per share excluding extraordinary items fell by -79.86%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg) | 0.65% |
---|---|
Div growth rate (5 year) | 19.14% |
Payout ratio (TTM) | 75.03% |
EPS growth(5 years) | 29.69 |
---|---|
EPS (TTM) vs TTM 1 year ago | -74.73 |
More ▼